-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Marinus Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2021 to Q3 2024.
- Marinus Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $29.6M, a 24% decline year-over-year.
- Marinus Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $156M, a 0.12% decline year-over-year.
- Marinus Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $162M, a 17.5% increase from 2022.
- Marinus Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $138M, a 23.1% increase from 2021.
- Marinus Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $112M, a 61.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)